Literature DB >> 34295710

The role of imaging in pulmonary hypertension.

Meenal Sharma1, Andrew T Burns1, Kelvin Yap1, David L Prior1,2.   

Abstract

Pulmonary hypertension (PH) is a debilitating and potentially life threatening condition in which increased pressure in the pulmonary arteries may result from a variety of pathological processes. These can include disease primarily involving the pulmonary vasculature, but more commonly PH may result from left-sided heart disease, including valvular heart disease. Chronic thromboembolic pulmonary hypertension (CTEPH) is an important disease to identify because it may be amenable to surgical pulmonary artery endarterectomy or balloon pulmonary angioplasty. Parenchymal lung diseases are also widespread in the community. Any of these disease processes may result in adverse remodeling of the right ventricle and progressive right heart (RH) failure as a common final pathway. Because of the breadth of pathological processes which cause PH, multiple imaging modalities play vital roles in ensuring accurate diagnosis and classification, which will lead to application of the most appropriate therapy. Multimodality imaging may also provide important prognostic information and has a role in the assessment of response to therapies which ultimately dictate clinical outcomes. This review provides an overview of the wide variety of established imaging techniques currently in use, but also examines many of the novel imaging techniques which may be increasingly utilized in the future to guide comprehensive care of patients with PH. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Pulmonary hypertension (PH); cardiac magnetic resonance; computed tomography; echocardiography; multimodality imaging; right ventricle

Year:  2021        PMID: 34295710      PMCID: PMC8261757          DOI: 10.21037/cdt-20-295

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  117 in total

Review 1.  Practical issues regarding the incorporation of PET into a busy SPECT practice.

Authors:  Gary V Heller
Journal:  J Nucl Cardiol       Date:  2012-02       Impact factor: 5.952

2.  Impaired stroke volume response to exercise in pulmonary arterial hypertension.

Authors:  Sebastiaan Holverda; C Tji-Joong Gan; J Tim Marcus; Pieter E Postmus; Anco Boonstra; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2006-03-29       Impact factor: 24.094

3.  Cardiac MRI: a new gold standard for ventricular volume quantification during high-intensity exercise.

Authors:  Andre La Gerche; Guido Claessen; Alexander Van de Bruaene; Nele Pattyn; Johan Van Cleemput; Marc Gewillig; Jan Bogaert; Steven Dymarkowski; Piet Claus; Hein Heidbuchel
Journal:  Circ Cardiovasc Imaging       Date:  2012-12-17       Impact factor: 7.792

Review 4.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

Review 5.  Clinical prediction rules for pulmonary embolism: a systematic review and meta-analysis.

Authors:  E Ceriani; C Combescure; G Le Gal; M Nendaz; T Perneger; H Bounameaux; A Perrier; M Righini
Journal:  J Thromb Haemost       Date:  2010-02-02       Impact factor: 5.824

6.  Prognostic value of right ventricular longitudinal peak systolic strain in patients with pulmonary hypertension.

Authors:  Marlieke L A Haeck; Roderick W C Scherptong; Nina Ajmone Marsan; Eduard R Holman; Martin J Schalij; Jeroen J Bax; Hubert W Vliegen; Victoria Delgado
Journal:  Circ Cardiovasc Imaging       Date:  2012-08-08       Impact factor: 7.792

7.  Pulmonary hypertension: how the radiologist can help.

Authors:  Elena Peña; Carole Dennie; John Veinot; Susana Hernández Muñiz
Journal:  Radiographics       Date:  2012 Jan-Feb       Impact factor: 5.333

8.  Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography: the Framingham Heart Study.

Authors:  Quynh A Truong; Joseph M Massaro; Ian S Rogers; Amir A Mahabadi; Matthias F Kriegel; Caroline S Fox; Christopher J O'Donnell; Udo Hoffmann
Journal:  Circ Cardiovasc Imaging       Date:  2011-12-16       Impact factor: 7.792

Review 9.  Advanced imaging tools rather than hemodynamics should be the primary approach for diagnosing, following, and managing pulmonary arterial hypertension.

Authors:  Mario Gerges; Christian Gerges; Irene M Lang
Journal:  Can J Cardiol       Date:  2015-01-28       Impact factor: 5.223

10.  Evaluation of patients with chronic thromboembolic pulmonary hypertension for pulmonary endarterectomy.

Authors:  William R Auger; Kim M Kerr; Nick H Kim; Peter F Fedullo
Journal:  Pulm Circ       Date:  2012 Apr-Jun       Impact factor: 3.017

View more
  1 in total

1.  Vascular remodeling of the small pulmonary arteries and measures of vascular pruning on computed tomography.

Authors:  Andrew J Synn; Constance De Margerie-Mellon; Sun Young Jeong; Farbod N Rahaghi; Iny Jhun; George R Washko; Raúl San José Estépar; Alexander A Bankier; Murray A Mittleman; Paul A VanderLaan; Mary B Rice
Journal:  Pulm Circ       Date:  2021-11-29       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.